Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids
Robert A Nathan, Hendrik Nolte, David S Pearlman, P04334 Study Investigators, Vibeke Backer
Dyk ned i forskningsemnerne om 'Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids'. Sammen danner de et unikt fingeraftryk.